Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-24-016469

Options or other derivatives

  • Galletta Christopher acquired 28,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Galletta Christopher

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-15 Grant or award : show line 1 in the form Stock Option (right to buy) +28,500 28,500 D
Loading xslF345X05/ownership.xml…